Cherwell publishes guide on environmental monitoring processes and validation
Supporting EM programs in preparation for proposed EU GMP Annex 1 changes.
Cherwell Laboratories, specialist supplier of products for environmental monitoring and process validation, has drawn on its in-depth pharmaceutical and related industry knowledge to publish an eBook titled, “The Environmental Monitoring Processes and Validation Guide.”
The new guide (available to download from Cherwell’s website) has been created following the release of the revised draft of EU GMP Annex 1 – Manufacture of Sterile Medicinal Products. It is intended to assist sterile product manufacturers with reviewing and improving their environmental monitoring (EM) programs in preparation for the proposed changes to Annex 1.
The comprehensive guide highlights the most business-efficient EM measures organisations can take to comply with the latest iteration of the EU GMP Annex 1, and practical steps they can take to create the ideal EM process. It also addresses and summarises the key changes proposed to Annex 1 and covers: Why the EU GMP Annex 1 draft has been proposed; how it helps all industries move closer towards a global standard; how to prepare for compliance; examples of best practice for EM programs and the right tools needed for an effective and compliant program.
Andrew Ramage, Cherwell Laboratories’ Microbiology Product Specialist comments: “The draft copy of the new version of EU GMP Annex 1 has considerably more detail on the expectations of designing and implementing an environmental monitoring regime. It remains to be seen how much will change following the public consultation. Regardless of what changes are made, our in-depth guide will help the end user to interpret the new guidelines and to create and implement a robust environmental monitoring regime for their cleanroom, whatever the size of their facility.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance